Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 3,772 MIRM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/Award | 3,772 | n/a |
| Jun 11, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Disposition to Issuer | 17,000 | n/a |
| Oct 2, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 30,000 | n/a |
| Jul 23, 2025 | Rein Therapeutics, Inc. (RNTX) | Grant/Award | 17,500 | n/a |
| Jun 13, 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale | 3,203 | $155.1K |
| Jun 2, 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 5,703 | n/a |
| Dec 6, 2024 | Aileron Therapeutics, Inc. (ALRN) | Grant/Award | 35,000 | n/a |
| Oct 4, 2024 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 10,000 | n/a |
| Aug 22, 2024 | Aileron Therapeutics, Inc. (ALRN) | Grant/Award | 2,725 | n/a |
| Jun 7, 2024 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/Award | 8,779 | n/a |